Literature DB >> 1504670

The bare lymphocyte syndrome.

J L Touraine1, G L Marseglia, H Betuel, G Souillet, L Gebuhrer.   

Abstract

The bare lymphocyte syndrome is a combined immunodeficiency resulting from the lack of expression of either class I or class II HLA antigens at the cell surface. The main clinical manifestations are infections of the respiratory or the digestive tract. The immunodeficiency involves the absence of antibody formation and the absence of cell-mediated response, to specific antigen, contrasting with virtually normal transplant immunity to allogeneic determinants. The responsible gene(s) is not born by chromosome 6. The best treatment appears, at the present time, to be in utero stem cell transplantation into the sick fetus, and it may, in the future, be gene therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1504670

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  2 in total

1.  RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency.

Authors:  B Durand; P Sperisen; P Emery; E Barras; M Zufferey; B Mach; W Reith
Journal:  EMBO J       Date:  1997-03-03       Impact factor: 11.598

2.  The peptide-receptive transition state of MHC class I molecules: insight from structure and molecular dynamics.

Authors:  Michael G Mage; Michael A Dolan; Rui Wang; Lisa F Boyd; Maria Jamela Revilleza; Howard Robinson; Kannan Natarajan; Nancy B Myers; Ted H Hansen; David H Margulies
Journal:  J Immunol       Date:  2012-06-29       Impact factor: 5.422

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.